drugset / Trial / NCT02113176
Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of a drug minocycline in improving outcomes at 3 months after rupture of an aneurysm in the head.
Timeline
- Start
- 2010-01
- Primary completion
- 2016-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 200 mg | Intravenous |